DocGo shares rise 20.28% intraday after reporting higher-than-expected Q4 revenue, raising 2026 guidance, and exploring strategic alternatives including potential sale or merger.

Tuesday, Mar 17, 2026 10:31 am ET1min read
DCGO--
DocGo surged 20.28% intraday as the company reported Q4 revenue of $74.9 million, exceeding expectations despite a decline due to winding down immigration projects, raised 2026 revenue guidance to $290M-$310M and narrowed adjusted EBITDA loss to $5M-$10M, and initiated a strategic review exploring potential sale or merger to maximize shareholder value.

Stay ahead of the market.

Get curated U.S. market news, insights and key dates delivered to your inbox.

Comments



Add a public comment...
No comments

No comments yet